Gainers
- Catheter Precision VTAK shares increased by 142.8% to $1.07 during Friday's regular session. The market value of their outstanding shares is at $3.0 million.
- Tevogen Bio Holdings TVGN shares moved upwards by 49.28% to $2.06. The market value of their outstanding shares is at $351.5 million.
- Quoin Pharmaceuticals QNRX stock rose 39.74% to $0.92. The company's market cap stands at $3.6 million.
- Carmell CTCX stock rose 30.56% to $0.63. The company's market cap stands at $13.1 million.
- Cyclacel Pharmaceuticals CYCC stock rose 30.46% to $1.32. The market value of their outstanding shares is at $2.6 million.
- Meihua Intl Medical Techs MHUA stock rose 27.86% to $1.15. The market value of their outstanding shares is at $29.2 million.
Losers
- NKGen Biotech NKGN shares fell 31.9% to $0.48 during Friday's regular session. The company's market cap stands at $16.8 million.
- Orgenesis ORGS shares declined by 28.05% to $2.33. The market value of their outstanding shares is at $11.1 million.
- Molecular Templates MTEM stock decreased by 16.1% to $0.78. The market value of their outstanding shares is at $5.1 million.
- Bullfrog AI Hldgs BFRG stock declined by 12.7% to $2.27. The company's market cap stands at $17.8 million.
- Chromocell Therapeutics CHRO shares decreased by 9.04% to $0.7. The market value of their outstanding shares is at $4.0 million.
- CareMax CMAX shares fell 8.84% to $1.96. The company's market cap stands at $7.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CHROChannel Therapeutics Corp
$0.64590.38%
CTCXCarmell Corp
$0.22863.72%
CYCCCyclacel Pharmaceuticals Inc
$0.33515.58%
MHUAMeihua International Medical Technologies Co Ltd
$0.31902.97%
MTEMMolecular Templates Inc
$0.1550-3.13%
NKGNNKGen Biotech Inc
$0.68997.80%
ORGSOrgenesis Inc
$1.76-16.5%
QNRXQuoin Pharmaceuticals Ltd
$0.5330-6.33%
TVGNTevogen Bio Holdings Inc
$0.9880-0.80%
VTAKCatheter Precision Inc
$0.35487.52%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in